Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium-Reference-Cited by-同舟云学术

Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium

Published:2023-07-19 Issue:9 Volume:65 Page:1343-1352
ISSN:0028-3940
Container-title:Neuroradiology
language:en
Short-container-title:Neuroradiology

Author:

Lee Matthew D.^ORCID,Patel Sohil H.^ORCID,Mohan Suyash^ORCID,Akbari Hamed^ORCID,Bakas Spyridon^ORCID,Nasrallah MacLean P.^ORCID,Calabrese Evan^ORCID,Rudie Jeffrey^ORCID,Villanueva-Meyer Javier^ORCID,LaMontagne Pamela^ORCID,Marcus Daniel S.^ORCID,Colen Rivka R.^ORCID,Balana Carmen^ORCID,Choi Yoon Seong^ORCID,Badve Chaitra^ORCID,Barnholtz-Sloan Jill S.^ORCID,Sloan Andrew E.^ORCID,Booth Thomas C.^ORCID,Palmer Joshua D.^ORCID,Dicker Adam P.^ORCID,Flanders Adam E.^ORCID,Shi Wenyin^ORCID,Griffith Brent^ORCID,Poisson Laila M.^ORCID,Chakravarti Arnab,Mahajan Abhishek^ORCID,Chang Susan,Orringer Daniel^ORCID,Davatzikos Christos^ORCID,Jain Rajan^ORCID,Bagley Stephen J.^ORCID,Bilello Michel^ORCID,Brem Steven^ORCID,Baid Ujjwal^ORCID,Desai Arati S.^ORCID,Lustig Robert A.^ORCID,Mamourian Elizabeth^ORCID,Kazerooni Anahita Fathi^ORCID,Garcia Jose A.,O’Rourke Donald M.^ORCID,Binder Zev A.^ORCID,Milchenko Mikhail^ORCID,Nazeri Arash^ORCID,Sotiras Aris^ORCID,Ak Murat^ORCID,Capellades Jaume^ORCID,Puig Josep^ORCID,Ahn Sung Soo^ORCID,Chang Jong Hee^ORCID,Lee Seung-Koo^ORCID,Park Yae Won^ORCID,Vadmal Vachan,Waite Kristin A.^ORCID,Gongala Sree,Chelliah Alysha^ORCID,Karami Golestan^ORCID,Alexander Gregory S.^ORCID,Ali Ayesha S.,Liem Spencer,Lombardo Joseph,Shukla Gaurav,Sharif Muhammad,Rogers Lisa R.,Taylor William,Cepeda Santiago^ORCID,Kotrotsou Aikaterini^ORCID,Fathallah-Shaykh Hassan^ORCID,Santonocito Orazio Santo^ORCID,Di Stefano Anna Luisa^ORCID,Rulseh Aaron M.^ORCID,Matsumoto Yuji^ORCID,Alexander Kimberley^ORCID,Satgunaseelan Laveniya^ORCID,Wiestler Benedikt^ORCID,Gullapalli Rao P.^ORCID,Melhem Elias R.,Woodworth Graeme F.,Kamel Peter I.,Perez-Garcia Victor M.^ORCID,Vamvakas Alekos,Tsougos Yiannis^ORCID,Valdes Pablo,Tiwari Pallavi^ORCID,Aboian Mariam^ORCID,

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Neurology (clinical),Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00234-023-03196-9.pdf

Reference29 articles.

1. Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251

2. Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807–1812

3. Beiko J, Suki D, Hess KR et al (2014) IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol 16(1):81–91

4. Patel SH, Poisson LM, Brat DJ et al (2017) T2-FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: a TCGA/TCIA project. Clin Cancer Res 23(20):6078–6085

5. Broen MPG, Smits M, Wijnenga MMJ et al (2018) The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study. Neuro Oncol 20(10):1393–1399

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction;American Journal of Neuroradiology;2024-01-18

2. The T2-FLAIR mismatch sign in oncologic neuroradiology: History, current use, emerging data, and future directions;The Neuroradiology Journal;2023-11-04